BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37354016)

  • 1. Investigating the inhibitory property of DM hCT on hCT fibrillization via its relevant peptide fragments.
    Chuang YP; Chang YP; Tu LH
    Protein Sci; 2023 Aug; 32(8):e4711. PubMed ID: 37354016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting Human Calcitonin Fibril Formation with Its Most Relevant Aggregation-Resistant Analog.
    Chen YT; Hu KW; Huang BJ; Lai CH; Tu LH
    J Phys Chem B; 2019 Dec; 123(48):10171-10180. PubMed ID: 31692350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the underlying mechanisms of reduced amyloidogenic properties in human calcitonin via double mutations.
    Chang YP; Pan PC; Tu LH
    Protein Sci; 2024 Apr; 33(4):e4952. PubMed ID: 38501491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine 12 of human calcitonin modulates its amyloid formation, membrane binding, and bioactivity.
    Hsieh IC; Chen TW; Chuang YP; Lai YJ; Tu LH
    Biochimie; 2022 Jun; 197():121-129. PubMed ID: 35240220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling the self-assembly of human calcitonin: a theoretical approach using molecular dynamics simulations.
    Paul S; Paul S
    Phys Chem Chem Phys; 2021 Jul; 23(26):14496-14510. PubMed ID: 34184696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Perturbation of Monomers Determines the Amyloid Aggregation Propensity of Calcitonin Variants.
    Liu Y; Wang Y; Zhang Y; Zou Y; Wei G; Ding F; Sun Y
    J Chem Inf Model; 2023 Jan; 63(1):308-320. PubMed ID: 36456917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-Conjugated Carbon Dots Inhibit Human Calcitonin Fibrillation.
    Wu JA; Chen YC; Tu LH
    Nanomaterials (Basel); 2021 Aug; 11(9):. PubMed ID: 34578556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue.
    Andreotti G; Vitale RM; Avidan-Shpalter C; Amodeo P; Gazit E; Motta A
    J Biol Chem; 2011 Jan; 286(4):2707-18. PubMed ID: 21078667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydrocaffeic Acid-Decorated Iron Oxide Nanomaterials Effectively Inhibit Human Calcitonin Aggregation.
    Shen CL; Wu YH; Zhang TH; Tu LH
    ACS Omega; 2022 Sep; 7(35):31520-31528. PubMed ID: 36092590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for the C-terminus of calcitonin in aggregation and gel formation: a comparative study of C-terminal fragments of human and salmon calcitonin.
    Moriarty DF; Vagts S; Raleigh DP
    Biochem Biophys Res Commun; 1998 Apr; 245(2):344-8. PubMed ID: 9571152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Insights into the Effects of F16L and F19L Substitutions on the Conformation and Aggregation Dynamics of Human Calcitonin.
    Huang F; Huang J; Yan J; Liu Y; Lian J; Sun Q; Ding F; Sun Y
    J Chem Inf Model; 2024 Jun; 64(11):4500-4510. PubMed ID: 38745385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Y12 nitration of human calcitonin (hCT): A promising strategy to produce non-aggregation bioactive hCT.
    Ye H; Li H; Gao Z
    Nitric Oxide; 2020 Nov; 104-105():11-19. PubMed ID: 32827754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of calcium ions on human calcitonin. Possible implications for bone resorption by osteoclasts.
    Meleleo D; Picciarelli V
    Biometals; 2016 Feb; 29(1):61-79. PubMed ID: 26596282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heme prevents highly amyloidogenic human calcitonin (hCT) aggregation: A potential new strategy for the clinical reuse of hCT.
    Ye H; Zhou J; Li H; Gao Z
    J Inorg Biochem; 2019 Jul; 196():110686. PubMed ID: 31003065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG.
    Huang R; Vivekanandan S; Brender JR; Abe Y; Naito A; Ramamoorthy A
    J Mol Biol; 2012 Feb; 416(1):108-20. PubMed ID: 22200484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the fibrillation of highly amyloidogenic human calcitonin by cucurbit[7]uril with improved bioactivity.
    Shang H; Zhou A; Jiang J; Liu Y; Xie J; Li S; Chen Y; Zhu X; Tan H; Li J
    Acta Biomater; 2018 Sep; 78():178-188. PubMed ID: 30076991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of aromatic residues in amyloid fibril formation of human calcitonin by solid-state 13C NMR and molecular dynamics simulation.
    Itoh-Watanabe H; Kamihira-Ishijima M; Javkhlantugs N; Inoue R; Itoh Y; Endo H; Tuzi S; Saitô H; Ueda K; Naito A
    Phys Chem Chem Phys; 2013 Jun; 15(23):8890-901. PubMed ID: 23552643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time.
    Kamgar-Parsi K; Hong L; Naito A; Brooks CL; Ramamoorthy A
    J Biol Chem; 2017 Sep; 292(36):14963-14976. PubMed ID: 28739873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design, conformational studies and bioactivity of highly potent conformationally constrained calcitonin analogues.
    Kapurniotu A; Kayed R; Taylor JW; Voelter W
    Eur J Biochem; 1999 Oct; 265(2):606-18. PubMed ID: 10504392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nanomolar concentrations of sodium dodecyl sulfate, a catalytic inductor of alpha-helices, on human calcitonin incorporation and channel formation in planar lipid membranes.
    Micelli S; Meleleo D; Picciarelli V; Stoico MG; Gallucci E
    Biophys J; 2004 Aug; 87(2):1065-75. PubMed ID: 15298911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.